Hospital operator HCA Healthcare (NYSE:HCA) exceeded Q3 CY2025 revenue expectations, reporting sales of $19.16 billion, up 9.6% year on year. Full-year revenue guidance of $75.75 billion is 0.9% above analysts’ estimates. GAAP profit of $6.96 per share beat consensus by 22.2%. The company attributes growth to increased Medicaid supplemental payments and disciplined cost controls. HCA plans to invest in digital tools, outpatient facilities, and workforce development for efficiency. Ongoing policy uncertainties could impact demand. Key factors for future performance include stable healthcare demand, resiliency initiatives, and policy changes affecting coverage. Stock currently trades at $447.25.

Source: https://stockstory.org/us/stocks/nyse/hca?utm_source=earningsCall&utm_medium=feed&utm_campaign=earningsCallIntroCTA

Read more at Stockstory.org does not belong to a specific media company.: Medicaid Payments, Volume Growth, and Outlook Shape Results